| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000036358 |
| Receipt No. | R000040185 |
| Scientific Title | Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety - |
| Date of disclosure of the study information | 2019/03/31 |
| Last modified on | 2019/03/31 (Ver. 1) |
| Basic information | ||
| Public title | Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety - | |
| Acronym | Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety - | |
| Scientific Title | Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety - | |
| Scientific Title:Acronym | Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety - | |
| Region |
|
|
| Condition | ||
| Condition | breast cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | efficacy and safety of Sentinel lymphnode biopsy treated with local anesthesia |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | detection rate of sentinel lymphnode |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | pretreat with local anesthesia ahead of RI injection | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | application of sentinel lymph node biosy
no allergy against local anesthesia informed consent |
|||
| Key exclusion criteria | allergy against local anesthesia | |||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Fukuyama City Hospital | ||||||
| Division name | Breast and Thyroid Surgery | ||||||
| Zip code | 721-8511 | ||||||
| Address | Zao-cho 5-23-1, Fukuyama, Hiroshima, Japan | ||||||
| TEL | 084-941-5151 | ||||||
| Shimin-byouin@city.fukuyama.hiroshima.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Fukuyama City Hospital | ||||||
| Division name | Breast and Thyroid Surgery | ||||||
| Zip code | 721-8511 | ||||||
| Address | Zao-cho 5-23-1, Fukuyama, Hiroshima, Japan | ||||||
| TEL | 084-941-5151 | ||||||
| Homepage URL | |||||||
| Shimin-byouin@city.fukuyama.hiroshima.jp | |||||||
| Sponsor | |
| Institute | Fukuyama City Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Fukuyama City Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | IRB(Fukuyama City Hospital) |
| Address | Zao-cho 5-23-1, Fukuyama, Hiroshima, Japan |
| Tel | 084-941-5151 |
| Shimin-byouin@city.fukuyama.hiroshima.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040185 |